<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">24767094</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>06</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1741-7015</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Apr</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC medicine</Title>
                <ISOAbbreviation>BMC Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>67</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/1741-7015-12-67</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe anemia (SA, hemoglobin &lt;6 g/dl) is a leading cause of pediatric hospital admission in Africa, with significant in-hospital mortality. The underlying etiology is often infectious, but specific pathogens are rarely identified. Guidelines developed to encourage rational blood use recommend a standard volume of whole blood (20 ml/kg) for transfusion, but this is commonly associated with a frequent need for repeat transfusion and poor outcome. Evidence is lacking on what hemoglobin threshold criteria for intervention and volume are associated with the optimal survival outcomes.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We evaluated the safety and efficacy of a higher volume of whole blood (30 ml/kg; Tx30: n = 78) against the standard volume (20 ml/kg; Tx20: n = 82) in Ugandan children (median age 36 months (interquartile range (IQR) 13 to 53)) for 24-hour anemia correction (hemoglobin &gt;6 g/dl: primary outcome) and 28-day survival.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Median admission hemoglobin was 4.2 g/dl (IQR 3.1 to 4.9). Initial volume received followed the randomization strategy in 155 (97%) patients. By 24-hours, 70 (90%) children in the Tx30 arm had corrected SA compared to 61 (74%) in the Tx20 arm; cause-specific hazard ratio = 1.54 (95% confidence interval 1.09 to 2.18, P = 0.01). From admission to day 28 there was a greater hemoglobin increase from enrollment in Tx30 (global P &lt;0.0001). Serious adverse events included one non-fatal allergic reaction and one death in the Tx30 arm. There were six deaths in the Tx20 arm (P = 0.12); three deaths were adjudicated as possibly related to transfusion, but none secondary to volume overload.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A higher initial transfusion volume prescribed at hospital admission was safe and resulted in an accelerated hematological recovery in Ugandan children with SA. Future testing in a large, pragmatic clinical trial to establish the effect on short and longer-term survival is warranted.</AbstractText>
                <AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.Gov identifier: NCT01461590 registered 26 October 2011.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Olupot-Olupot</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Engoru</LastName>
                    <ForeName>Charles</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thompson</LastName>
                    <ForeName>Jennifer</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nteziyaremye</LastName>
                    <ForeName>Julius</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chebet</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ssenyondo</LastName>
                    <ForeName>Tonny</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dambisya</LastName>
                    <ForeName>Cornelius M</ForeName>
                    <Initials>CM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okuuny</LastName>
                    <ForeName>Vicent</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wokulira</LastName>
                    <ForeName>Ronald</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amorut</LastName>
                    <ForeName>Denis</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ongodia</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mpoya</LastName>
                    <ForeName>Ayub</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Thomas N</ForeName>
                    <Initials>TN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Uyoga</LastName>
                    <ForeName>Sophie</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Macharia</LastName>
                    <ForeName>Alex</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gibb</LastName>
                    <ForeName>Diana M</ForeName>
                    <Initials>DM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walker</LastName>
                    <ForeName>A Sarah</ForeName>
                    <Initials>AS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maitland</LastName>
                    <ForeName>Kathryn</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Kilifi Clinical Trials Facility, KEMRI-Wellcome Trust Research Programme, PO Box 230, Kilifi, Kenya. k.maitland@imperial.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT01461590</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>091758</GrantID>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>092654</GrantID>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/J012483/1</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>G0801439</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>04</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Med</MedlineTA>
            <NlmUniqueID>101190723</NlmUniqueID>
            <ISSNLinking>1741-7015</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>9034-51-9</RegistryNumber>
                <NameOfSubstance UI="D006441">Hemoglobin A</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>BMC Med. 2014;12:68</RefSource>
                <PMID Version="1">24767140</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000349" MajorTopicYN="N">Africa</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001803" MajorTopicYN="Y">Blood Transfusion</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006441" MajorTopicYN="Y">Hemoglobin A</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D065227" MajorTopicYN="N">Transfusion Reaction</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>03</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>6</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24767094</ArticleId>
            <ArticleId IdType="pii">1741-7015-12-67</ArticleId>
            <ArticleId IdType="doi">10.1186/1741-7015-12-67</ArticleId>
            <ArticleId IdType="pmc">PMC4101869</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Transfus Med. 2010 Jun;20(3):140-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20210924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nutr. 2001 Feb;131(2S-2):636S-645S; discussion 646S-648S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11160595</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2008;3(8):e2903</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18682797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2007 Mar;4(3):e66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17355169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Epidemiol. 2006 Jun;35(3):691-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16507643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2005 Jul;11(7):1118-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16022794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 2005 Jul;90(7):724-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15970617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2005 Jul 1;106(1):368-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15769889</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Lab Med. 1996 Dec;16(4):895-906</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8974201</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1995 Jul 20;376(6537):246-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7617034</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 1994 Aug;8(8):1135-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7986412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 1993 Jul;7(7):995-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8357559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1992 Aug 29;340(8818):524-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1354285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2003 Feb 15;326(7385):361</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12586667</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2002 Feb 9;359(9305):494-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11853798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Matern Child Nutr. 2014 Jan;10(1):135-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22973867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 Oct 17;374(9698):1364-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19747721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2012;9(9):e1001309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22984355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2011 Jun 30;364(26):2483-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21615299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Med. 2011;9:37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21486498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2010 Sep 9;116(10):1663-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20530796</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>